MedPath

Strategy + RehaCom for Memory Rehabilitation in Traumatic Brain Injury (TBI)

Not Applicable
Conditions
Traumatic Brain Injury With Loss of Consciousness
Registration Number
NCT04239456
Lead Sponsor
Kessler Foundation
Brief Summary

The purpose of this research study is to evaluate the effectiveness of "RehaCom," a computerized treatment for memory deficits, in a 16-session, interactive course. Following a manualized approach, the Rehacom modules will be used for the repeated application of the content acquired during 1-on-1 memory strategy training. The goal is to improve face/name, list and verbal memory of patients who survived a moderate to severe traumatic brain injury.

Detailed Description

This randomized clinical trial (RCT) consists of 20 chronic moderate-to-severe TBI patients who will receive memory strategy training and complete three memory modules of the RehaCom at one of the Kessler Foundation locations. Changes in attention, processing speed, verbal/non-verbal new learning and memory (NLM) and executive control will be assessed via pre/post and 3-month follow-up assessments before and after the 8-10 week intervention. Self-report questionnaires will also track functional and emotional outcomes such as mood and anxiety, cognition, quality of life, self-efficacy, deficit awareness, community participation, and readiness for occupational functioning

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Able to read and speak English fluently at the 5th grade level (for testing; software has multilingual support)
  • Had a TBI at least 1 year ago
  • No history of learning disorders during school years
  • Able to use a personal computer (PC) non-stop for 1 hour without health or visual complaints; able to press keyboard buttons.No history of learning disorders
Exclusion Criteria
  • Actively participating in another intervention study
  • Distance to Kessler Foundation East Hanover or West Orange location is more than 20 miles.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) - Story Memory performancebaseline & 10-14 weeks after baseline assessment

Raw scores from Story A and Story B recall \[0-50\], where higher scores indicate better recall.

Change in Wechsler Memory Scale III - Faces II performancebaseline & 10-14 weeks after baseline assessment

Delayed Recall Score \[0-48\] where higher scores indicate better recall.

Change in California Verbal Learning Test - II (CVLT-II) performanceBaseline & 10-14 weeks after baseline assessment

We will use the raw scores for free and cued delayed recall \[0-16\] where higher scores indicate better verbal recall.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Kessler Foundation

🇺🇸

East Hanover, New Jersey, United States

Kessler Foundation
🇺🇸East Hanover, New Jersey, United States
© Copyright 2025. All Rights Reserved by MedPath